ITGAE and breast carcinoma: The increase in tumor‐infiltrating CD103+DCs was reported to be closely associated with the anti‐tumor effects in different kinds of cancer, including metastatic melanoma, breast cancer, and lung adenocarcinoma.64, 71, 72